Cylene Pharma Raises $44 Million

Cylene Pharmaceuticals Inc., a San Diego-based oncology drug discovery and development company, has raised $44 million in Series C funding. HBM BioVentures and Lilly Ventures co-led the deal, and were joined by Sanderling Ventures, Novartis BioVenture Fund, BioVentures Investors, Research Corp. Technologies, Mitsui & Co. Venture Partners and Celgene Corporation.< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />